Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DGIST Holdings is the investment and technology commercialization arm of the Daegu Gyeongbuk Institute of Science and Technology (DGIST) in South Korea. The organization manages the DGIST Start-up Fund Program, which provides seed capital and acceleration services to early-stage ventures originating from the institute's research. Its portfolio includes a significant number of companies in the life sciences, biotechnology, and healthcare sectors, focusing on translating academic innovations into commercial products. DGIST Holdings supports its startups through mentoring, infrastructure, and follow-on investment opportunities. By bridging the gap between laboratory research and the global market, the program plays a vital role in the South Korean deep-tech ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DGIST Start-up Fund Program.